Navigation Links
BRCA Mutations Don't Spot All High-Risk Women
Date:5/5/2008

Family history and atypical cells also indicate high risk of second cancer, study finds,,

MONDAY, May 5 (HealthDay News) -- In women who have been diagnosed with breast cancer, having a known mutation in the BRCA 1 or 2 genes raises the risk of a second cancer, and many of these women choose to have their second breast removed before that has a chance to happen.

However, new research suggests that women who don't have these genetic mutations may still face an increased risk of a second cancer, especially if they have a family history of breast cancer or atypical breast cells.

The study involved women with a family history of breast cancer, although only some had a BRCA mutation. The researchers found that the risk of cancer in the second breast was about 10 percent, regardless of whether the woman carried a BRCA mutation or not.

The findings were slated to be presented Sunday at the American Society of Breast Surgeons' annual meeting, in New York City.

The study suggests that "we may not have identified all of the genes associated with breast cancer," according to study author Dr. Shawna Willey, director of the Betty Lou Ourisman Breast Health Center at the Lombardi Cancer Center at Georgetown University in Washington D.C.

Many high-risk women may not be advised to have a prophylactic mastectomy even though it could be potentially lifesaving, she added.

"Having a prophylactic mastectomy should not be a knee-jerk reaction to a diagnosis of breast cancer. Women need to consider this data, as well as other data, and decide whether or not this is a measure they want to take," advised Willey. She said the findings may also add to the debate about which breast cancer patients should have sentinel lymph node biopsies.

"Prevention of secondary breast cancer is becoming increasingly important," said Dr. Julia Smith, director of the Lynne Cohen Breast Cancer Preventative Care Program at the New York University Cancer Institute in New York City. "Because of advances in treatment, it's possible that many younger women with breast cancer may live for decades, so we have to focus on what we can do to prevent a further problem."

And, she said, many of the effective chemotherapy drugs can't be used a second time because they may be too toxic to healthy cells if given repeatedly, and cancer cells can become resistant to some forms of chemotherapy.

"We use our best treatment at the time to try to ensure long-term survival, but if another breast cancer comes along, we may be limited," she said.

While women with BRCA mutations are known to have a higher risk of developing an additional cancer, Willey and her colleagues wanted to learn if women with a family history but no known BRCA mutations carried a similar risk.

The analysis included 119 women who were part of the Familial Cancer Registry. All of the women had been diagnosed with an initial breast cancer, and had decided to prophylactically remove the second breast.

When the researchers analyzed the breast tissue from the second breast, they found cancer about 10 percent of the time, regardless of whether or not a woman had a BRCA mutation.

If the normal breast cancer cells were atypical -- meaning they showed precancerous changes -- the risk of breast cancer jumped to about 50 percent over a lifetime for a woman with a family history of the disease, according to Willey.

"Not having a BRCA mutation doesn't let you off the hook," Smith noted.

"There's no question that family history is extremely important. Even without a BRCA mutation, we counsel women to consider prophylactic mastectomy if they have a strong family history," she added.

More information

To learn more about prophylactic mastectomy, visit the National Cancer Institute.



Sources: Shawna Willey, M.D., director, Betty Lou Ourisman Breast Health Center, Lombardi Cancer Center, Georgetown University Hospital, Washington D.C.; Julia Smith, M.D., director, Lynne Cohen Breast Cancer Preventative Care Program, and director, Breast Cancer Screening and Prevention Program, New York University Cancer Institute and Bellevue Hospital, New York City; May 4, 2008, presentation, American Society of Breast Surgeons' annual meeting, New York City


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Second breast cancer may be greater than thought for high-risk women without BRCA mutations
2. Different mutations in single gene suggest Parkinsons is primarily an inherited genetic disorder
3. Gene Mutations for Rare Heart Disease Also Found in Kids
4. Einstein researchers discover gene mutations linked to longer lifespans
5. 2 Mutations Were Critical to Spread of 1918 Flu
6. Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations
7. Scientists explore factors contributing to DNA mutations
8. Genetic Mutations Boost Prostate Cancer Risk
9. BRCA Mutations Dont Raise Breast Cancer Risk Equally
10. Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
11. Gene Mutations May Cause Rare Neonatal Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BRCA Mutations Don't Spot All High-Risk Women
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: